Dr. Reddy’s and GSK Form Alliance in Emerging Markets

Dr. Reddy’s Laboratories (Hyderabad, India) says it has entered into an agreement with GlaxoSmithKline (GSK; London) to develop and market select products in several emerging markets, excluding India. Financial terms of the deal were not disclosed. Hussain: Demand for drugs rising in some regions. Dr. Reddy’s says this is the first such alliance between the two companies. The deal calls for GSK to gain exclusive access to Dr. Reddy’s portfolio and future pipeline of more than 100 branded pharmaceuticals in fast-growing therapeutic segments such...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers